Circumscript myositis ossificans in a four-year-old boy;Miositis osificante circunscrita en un niño de cuatro años

Revista Espanola de Medicina Nuclear

Volumn 27, Issue 5, 2008, Pages 358-362

  Cabello Garcia D ^a   Rodriguez Fernandez A ^a   Gomez Rio M ^a   Moreno, M J ^a   Rebollo Aguirre, A C ^a   Martin Castro A ^a   Llamas Elvira, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Bone scintigraphy; Myositis ossificans; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OXIDRONATE TECHNETIUM TC 99M;

ARM DISEASE; ARTICLE; BONE BIOPSY; BONE SCINTISCANNING; CASE REPORT; CHILD CARE; CLINICAL FEATURE; DISEASE COURSE; HUMAN; HUMAN TISSUE; MALE; OSSIFYING MYOSITIS; OSTEOSARCOMA; PAIN; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD;

EID: 55549130466     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1157/13126193     Document Type: Article

References (19)

1. Elgazzar AH. Diagnosis of soft tissue calcification. En: Orthopedic nuclear medicine. Berlin: Springer-Verlag Berlin Heidelberg; 2004. p. 200-7.
2. Shih WJ, Hackett MT, Stipp V, Gross K, Pulmano C. Myositis ossificans demonstrated by positive gallium-67 and technetium-99m-HMDP bone imaging but negative technetium-99m-MIBI imaging. J Nucl Med Technol. 1999;27:48-50.
3. Goldman AB. Myositis ossificans circumscripta: a benign lesion with a malignant differential diagnosis. AJR Am J Roentgenol. 1976;126:32-40.
4. Minoves Font M, Riera Gil E. Traumatic and sports related injuries. Soft tissue lesions. Muscle injuries. En: Domènech-Torné FM, Setoain Quinquer J, editors. Nuclear Medicine imaging in benign bone and joint diseases. Barcelona: Masson; 2005. p. 250-4.
5. Storey G, Murray IPC. Bone scintigraphy: the procedure and interpretation. En: Ell PJ, Gambhir SS, editors. Nuclear medicine in clinical diagnosis and treatment. United Kingdom: Elsevier; 2004. p. 614-5.
6. Güngör F, Yazici M, Egehan I, Demirçali AE, Sahin M, Cakir S, et al. Thallium-201 uptake in myositis ossificans. Potential pitfall in diagnosis. Clin Nucl Med. 1995;20:259-62.
7. Tanaka T, Rossier AB, Hussey RW, Ahnberg DS, Treves S. Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. Radiology. 1977;123:217-21.
8. Alonso Calderón JL, Delgado Valdueza J, Deprada Vicente I. Miositis osificante circunscrita axilar. An Pediatr (Barc). 2004;60:373-5.
9. Salzman L, Lee VW, Grant P. Gallium uptake in myositis ossificans. Potential pitfalls in diagnosis. Clin Nucl Med. 1987;12:308-18.
10. Yazici M, Etensel B, Gürsoy MH, Aydogdu A, Erkus M. Non-traumatic myositis ossificans with an unusual location: case report. J Pediatr Surg. 2002;37:1621-2.
11. Mulier S, Stas M, Delabie J, Lateur L, Gysen M, Dal Cin P, et al. Proliferative myositis in a child. Skeletal Radiol. 1999;28:703-9.
12. Ackerman L. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called Myositis ossificans). Clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg (Am). 1958;40-A:279.
13. Ackerman L, Ramamurthy S, Jablokow V, Van Drunen M, Kaplan E. Case report 488: Post-traumatic myositis ossificans mimicking a soft tissue neoplasm. Skeletal Radiol. 1988;17:310-4.
14. Khoury J, Jerushalmi J, Loberant N. Tc-99m MIBI/Tc-99m MDP mismatch: a useful scintigraphic finding in differentiating myositis ossificans from malignant tumor of soft tissue. Clin Nucl Med. 2006;31:547-9.
15. Morris SJ, Trieu J, Chin R, Allman K, Van Der Wall H. Fibula stress fracture and confounding myositis ossificans. Clin Nucl Med. 2004;29:813-4.
16. Sud AM, Wilson MW, Mountz JM. Unusual clinical presentation and scintigraphic pattern in myositis ossificans. Clin Nucl Med. 1992;17:198-9.
17. Parikh J, Hyare H, Saifuddin A. The imaging features of posttraumatic myositis ossificans, with emphasis on MRI. Clin Radiol. 2002;57:1058-66.
18. Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med. 1999;26:599-605.
19. Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev. 2004;30:83-101.